| If you have not already registered for Full Text Access to The Journal, then visit our registration page. | VOLUME 68 2007 NUMBER 12Original Articles 1828 Mortality Risk in Patients With Schizophrenia Participating in
Premarketing Atypical Antipsychotic Clinical Trials. Arif Khan, Kelly
Schwartz, Chelsea Stern, Nick Redding, Russell L. Kolts, Walter A. Brown, and
Donald S. Robinson 1834 Adiponectin as a Potential Biomarker for the Metabolic Syndrome in
Chinese Patients Taking Clozapine for Schizophrenia. Ya Mei Bai, Jen-Yeu
Chen, Wei-Shiung Yang, Yu-Chiao Chi, Ying-Jay Liou, Chao-Cheng Lin, Ying-Chieh
Wang, Chih-Yuan Lin, Tung-Pine Su, and Pesus Chou 1840 Divalproex in the Treatment of Acute Bipolar Depression: A Preliminary
Double-Blind, Randomized, Placebo-Controlled Pilot Study. S. Nassir Ghaemi,
William S. Gilmer, Joseph F. Goldberg, Benjamin Zablotsky, David E. Kemp, Mary
E. Kelley, Amber D. Bauer, Jenelle Fleck, Megan M. Filkowski, Vanessa A. Stan,
and Robert T. Dunn 1845 Paroxetine Versus Placebo and Other Agents for Depressive Disorders: A
Systematic Review and Meta-Analysis. Martin A. Katzman, Andrea C. Tricco,
Diane McIntosh, Marie J. Filteau, Pierre Bleau, Pratap R. Chokka, Kevin D.
Kjernisted, Hiram Mok, and Ba' Pham 1860 Symptoms of Sexual Dysfunction in Patients Treated for Major Depressive
Disorder: A Meta-Analysis Comparing Selegiline Transdermal System and Placebo
Using a Patient-Rated Scale. Anita H. Clayton, Bryan J. Campbell, Antonella
Favit, Ying Yang, George Moonsammy, Catherine M. Piontek, and Jay D. Amsterdam
1867 Ethyl-Eicosapentaenoic Acid in First-Episode Psychosis: A Randomized,
Placebo-Controlled Trial. Gregor E. Berger, Tina-Marie Proffitt, Mirabel
McConchie, HokPan Yuen, Stephen J. Wood, G. Paul Amminger, Warrick Brewer, and
Patrick D. McGorry 1876 Comparison of Intramuscular Ziprasidone, Olanzapine, or Aripiprazole for
Agitation: A Quantitative Review of Efficacy and Safety. Leslie Citrome
1886 Quality of Treatment and Disability Compensation in Depression:
Comparison of 2 Nationally Representative Samples With a 10-Year Interval in
Finland. Teija I. Honkonen, Timo A. Aro, Erkki T. Isometsä, E. Marianna
Virtanen, and Heikki O. Katila 1894 The Role of Craving in Relapse After Discontinuation of Long-Term
Benzodiazepine Use. [CME] Audrey J. J.
Mol, Richard C. Oude Voshaar, Wim J. M. J. Gorgels, Marinus H. M. Breteler,
Anton J. L. M. van Balkom, Eloy H. van de Lisdonk, Cornelis C. Kan, and Frans G.
Zitman 1901 Comparative Assessment of the Incidence and Severity of Tardive
Dyskinesia in Patients Receiving Aripiprazole or Haloperidol for the Treatment
of Schizophrenia: A Post Hoc Analysis. Del D. Miller, James M. Eudicone,
Andrei Pikalov, and Edward Kim 1907 Comparing the Rapidity of Response During Treatment of Major Depressive
Disorder With Bupropion and the SSRIs: A Pooled Survival Analysis of 7
Double-Blind, Randomized Clinical Trials. George I. Papakostas, Stuart A.
Montgomery, Michael E. Thase, Judith R. Katz, Alok Krishen, and Vivian L. Tucker
1913 The Fundamental Structure of Axis II Personality Disorders Assessed in
the National Epidemiologic Survey on Alcohol and Related Conditions. Brian J.
Cox, Jitender Sareen, Murray W. Enns, Ian Clara, and Bridget F. Grant 1921 A Comparison of Initial Duloxetine Dosing Strategies in Patients With
Major Depressive Disorder. Virgil G. Whitmyer, David L. Dunner, Susan G.
Kornstein, Adam L. Meyers, Craig H. Mallinckrodt, Madelaine M. Wohlreich, Jill
S. Gonzales, and John H. Greist 1931 Are Depressed Outpatients With and Without a Family History of Substance
Use Disorder Different?A Baseline Analysis of the STAR*D Cohort. Lori L.
Davis, Elizabeth C. Frazier, Bradley N. Gaynes, Madhukar H. Trivedi, Stephen R.
Wisniewski, Maurizio Fava, Jennifer Barkin, T. Michael Kashner, Richard C.
Shelton, Jonathan E. Alpert, and A. John Rush 1939 Alcohol and Cannabis Use in Urban, African American, First-Episode
Schizophrenia-Spectrum Patients: Associations With Positive and Negative
Symptoms. Michael T. Compton, Neil E. Whicker, and Karen M. Hochman Focus on Women's Mental Health 1946 Screening and Treatment for Women With Mood Disorders Associated With
Reproductive Events. Marlene P. Freeman 1947 Family and Partner Psychopathology and the Risk of Postpartum Mental
Disorders. Trine Munk-Olsen, Thomas Munk Laursen, Carsten Bøcker Pedersen,
Ole Mors, and Preben Bo Mortensen 1954 Treatment of Premenstrual Worsening of Depression With Adjunctive Oral
Contraceptive Pills: A Preliminary Report. Hadine Joffe, Laura F. Petrillo,
Adele C. Viguera, Hannah Gottshcall, Claudio N. Soares, Janet E. Hall, and Lee
S. Cohen Commentary 1963 Diagnosing and Managing Complicated ADHD. [CME]
Robert L. Findling, L. Eugene Arnold, Laurence L. Greenhill,
Christopher J. Kratochvil, and James J. McGough Academic Highlights 1971 Diagnosis and Treatment Strategies for Mixed Episodes in Bipolar
Disorder. [CME] ASCP Corner 1982 What Constitutes Evidence-Based Pharmacotherapy for Bipolar Disorder?
Part 1: First-Line Treatments. Joseph F. Goldberg Letters To the Editor [PDF] 1984 More on Placebo Response. Jeffrey Allan Mattes
1985 Corpus Callosum Dysplasia in Adult Attention-Deficit/Hyperactivity Disorder: A Case Report. Alexandra Philipsen, Ludger Tebartz van Elst, Evgeniy Perlov, Dieter Ebert, and Bernd Hesslinger 1988 Treatment of Cognitive Deficits in Schizophrenia With Atomoxetine: A Case Report. Naren P. Rao, Ganesan Venkatasubramanian, and Bangalore N. Gangadhar 1989 A Case of Olanzapine-Induced Gestational Diabetes Mellitus in the Absence of Weight Gain. Mytilee P. Vemuri and Natalie L. Rasgon 1989 Correction. Viguera AC, Koukopoulos A, Muzina DJ, and Baldessarini
RJ. Teratogenicity and anticonvulsants: lessons from neurology to psychiatry
(J Clin Psychiatry 2007;68[suppl 9]:29-33) Book Reviews 1990 [PDF] Electronic CME Activities Available through www.psychiatrist.com/toc e29 What Clinicians Need to Know About Neuroprotective Issues in Bipolar Disorder.
Vladimir Maletic e30 Recognition and Treatment of Obsessive-Compulsive Disorder. Wayne K. Goodman and R.
Bruce Lydiard e31 Identifying and Treating Cognitive Impairments in Elderly Patients. Steven P. Roose |